ScholarIQanswers from OpenAlex

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib

PaperCitations, authors & open-access status

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib have?

ScholarIQcitation count

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib has 184 citations in the OpenAlex counts ScholarIQ stores.

When was Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib published?

ScholarIQyear

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib has 2008 year in the ScholarIQ index.

What is the open-access status of Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib?

ScholarIQoa status

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib has bronze oa status in the ScholarIQ index.

What is the DOI of Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib?

ScholarIQdoi

The DOI for Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib is on the source record.

What is the PMID of Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib?

ScholarIQpmid

The PMID for Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib is on the source record.

What is the OpenAlex record for Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib?

ScholarIQopenalex

The OpenAlex for Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial